Anna Fábián

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 20

Top Topics

Cross Sectional

Ulcerative Colitis

Patients With Inflammatory Bowel Disease

Top Venues

Therapeutic advances in gastroenterology

Expert opinion on biological therapy

Expert opinion on drug safety

Scandinavian journal of gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Péter Bacsur, Panu Wetwittayakhlang, Tamás Resál, Emese Földi, Béla Vasas, Bernadett Farkas, Mariann Rutka, Talat Bessissow, Waqqas Afif, Anita Bálint, Anna Fábián, Renáta Bor, Zoltán Szepes, Klaudia Farkas, Peter L Lakatos, Tamás Molnár
Accuracy of the Pancolonic Modified Mayo Score in predicting the long-term outcomes of ulcerative colitis: a promising scoring system. Therapeutic advances in gastroenterology 17 (2024)
Péter Bacsur, Panu Wetwittayakhlang, Tamás Resál, Emese Földi, Béla Vasas, Bernadett Farkas, Mariann Rutka, Talat Bessissow, Waqqas Afif, Anita Bálint, Anna Fábián, Renáta Bor, Zoltán Szepes, Klaudia Farkas, Peter L Lakatos, Tamás Molnár
Accuracy of the Pancolonic Modified Mayo Score in predicting the long-term outcomes of ulcerative colitis: a promising scoring system. Therapeutic advances in gastroenterology 17 (2024)
Tamás Resál, Katalin Mangó, Péter Bacsur, Kata Judit Szántó, Daniella Pigniczki, Csilla Keresztes, Mariann Rutka, Anita Bálint, Ágnes Milassin, Renáta Bor, Anna Fábián, Zoltán Szepes, Klaudia Farkas, Katalin Monostory, Tamás Molnár
Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone. Expert opinion on drug safety (2023)
Péter Bacsur, Mariann Rutka, András Asbóth, Tamás Resál, Kata Judit Szántó, Boldizsár Jójárt, Anita Bálint, Eszter Ari, Walliyulahi Ajibola, Bálint Kintses, Tamás Fehér, Daniella Pigniczki, Renáta Bor, Anna Fábián, József Maléth, Zoltán Szepes, Klaudia Farkas, Tamás Molnár
Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls. Therapeutic advances in gastroenterology 16 (2023)
Tamás Resál, Katalin Mangó, Péter Bacsur, Kata Judit Szántó, Daniella Pigniczki, Csilla Keresztes, Mariann Rutka, Anita Bálint, Ágnes Milassin, Renáta Bor, Anna Fábián, Zoltán Szepes, Klaudia Farkas, Katalin Monostory, Tamás Molnár
Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone. Expert opinion on drug safety (2023)
Tamás Resál, Péter Bacsur, Miklós Horváth, Kata Judit Szántó, Mariann Rutka, Anita Bálint, Anna Fábián, Renáta Bor, Zoltán Szepes, János Fekete, Klaudia Farkas, Pál Miheller, Tamás Molnár
Nationwide experiences with trough levels, durability, and disease activity among inflammatory bowel disease patients following COVID-19 vaccination. Therapeutic advances in gastroenterology 16 (2023)
Péter Bacsur, Mária Matuz, Tamás Resál, Pál Miheller, Tamás Szamosi, Eszter Schäfer, Patricia Sarlos, Ákos Iliás, Kata Judit Szántó, Mariann Rutka, Anita Bálint, Ágnes Csontos, Anna Fábián, Renáta Bor, Zoltán Szepes, Tamás Molnár, Klaudia Farkas
Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn's disease: results from a multicentre cohort study. Therapeutic advances in gastroenterology 15 (2022)
Péter Bacsur, Mária Matuz, Tamás Resál, Pál Miheller, Tamás Szamosi, Eszter Schäfer, Patricia Sarlos, Ákos Iliás, Kata Judit Szántó, Mariann Rutka, Anita Bálint, Ágnes Csontos, Anna Fábián, Renáta Bor, Zoltán Szepes, Tamás Molnár, Klaudia Farkas
Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn's disease: results from a multicentre cohort study. Therapeutic advances in gastroenterology 15 (2022)
Kata Judit Szántó, Tamara Madácsy, Diána Kata, Tamás Ferenci, Mariann Rutka, Anita Bálint, Renáta Bor, Anna Fábián, Ágnes Csontos, Boldizsár Jójárt, Zoltán Szepes, Ferenc Nagy, Tamás Molnár, Imre Földesi, József Maléth, Klaudia Farkas
Advances in the optimization of therapeutic drug monitoring using serum, tissue and faecal anti-tumour necrosis factor concentration in patients with inflammatory bowel disease treated with TNF-α antagonists. Expert opinion on biological therapy 21 (4) (2021)
Mariann Rutka, Renáta Bor, Tamás Molnár, Klaudia Farkas, Daniella Pigniczki, Anna Fábián, Márk Györffy, Anita Bálint, Ágnes Csontos, Mónika Szücs, László Tiszlavicz, Ferenc Nagy, Zoltán Szepes
Efficacy of the population-based pilot colorectal cancer screening, Csongrád county, Hungary, 2015 Turkish journal of medical sciences 50 (4) (2020)
Renáta Bor, Béla Vasas, Anna Fábián, Mónika Szücs, Árpád Füredi, László Czakó, Mariann Rutka, Klaudia Farkas, Tamás Molnár, Ágnes Csontos, Anita Bálint, Kata Judit Szántó, Sándor Hamar, László Kaizer, László Tiszlavicz, Zoltán Szepes
Slow-pull technique yields better quality smears: prospective comparison of slow-pull and standard suction techniques of endoscopic ultrasound-guided fine-needle aspiration. Scandinavian journal of gastroenterology 55 (11) (2020)
Anna Fábián, Renáta Bor, Ella Szabó, Viktor Kardos, Anita Bálint, Klaudia Farkas, Ágnes Milassin, Mariann Rutka, Kata Szántó, Tamás Molnár, Mónika Szűcs, Katalin Lőrinczy, Ákos Orbán-Szilágyi, Tibor Gyökeres, György Gyimesi, Attila Szepes, Valéria Kovács, István Rácz, Zoltán Szepes
Endoscopic treatment of gastric antral vascular ectasia in real-life settings: Argon plasma coagulation or endoscopic band ligation? Journal of digestive diseases 22 (1) (2020)
Anna Fábián, Renáta Bor, Klaudia Farkas, Zoltán Szepes, Tamás Molnár
Letter: long-term outcomes of patients with acute severe ulcerative colitis after intravenous steroid therapy. Alimentary pharmacology & therapeutics 52 (7) (2020)
Renáta Bor, Anna Fábián, Mária Matuz, Zoltán Szepes, Klaudia Farkas, Pál Miheller, Tamás Szamosi, Áron Vincze, Mariann Rutka, Kata Judit Szántó, Anita Bálint, Ferenc Nagy, Ágnes Csontos, Tibor Tóth, Ferenc Zsigmond, Judit Bajor, Katalin Müllner, Lilla Lakner, Mária Papp, Ágnes Salamon, Gábor Horváth, Krisztina Sarang, Eszter Schäfer, Patrícia Sarlós, Károly Palatka, Tamás Molnár
Real-life efficacy of vedolizumab on endoscopic healing in inflammatory bowel disease - A nationwide Hungarian cohort study. Expert opinion on biological therapy 20 (2) (2019)
Renáta Bor, Anna Fábián, Klaudia Farkas, Tamás Molnár, Zoltán Szepes
Human mesenchymal stem cell therapy in the management of luminal and perianal fistulizing Crohn's disease - review of pathomechanism and existing clinical data. Expert opinion on biological therapy 18 (7) (2018)
Anita Bálint, Mariann Rutka, Martin Kolar, Dana Duricova, Veronika Hruba, Katarina Mitrova, Karin Malickova, Milan Lukas, Zoltán Szepes, Ferenc Nagy, Károly Palatka, Szilvia Lovas, Zsuzsanna Végh, Zsuzsanna Kürti, Ágnes Csontos, Pál Miheller, Tibor Nyári, Renáta Bor, Anna Fábián, Kata Judit Szántó, Péter L Lakatos, Tamás Molnár, Klaudia Farkas
Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis - results from multicenter observational cohort. Expert opinion on biological therapy 18 (11) (2018)
Anna Fábián, Mariann Rutka, Tamás Ferenci, Renáta Bor, Anita Bálint, Klaudia Farkas, Ágnes Milassin, Kata Szántó, Zsuzsanna Lénárt, Ferenc Nagy, Zoltán Szepes, Tamás Molnár
The Use of Complementary and Alternative Medicine Is Less Frequent in Patients with Inflammatory Bowel Disease Than in Patients with Other Chronic Gastrointestinal Disorders. Gastroenterology research and practice 2018 (2018)
Anita Bálint, Mariann Rutka, Zsuzsanna Végh, Zsuzsanna Kürti, Krisztina B Gecse, János Banai, László Bene, Beáta Gasztonyi, Tünde Kristóf, László Lakatos, Pál Miheller, Károly Palatka, Árpád Patai, Ágnes Salamon, Tamás Szamosi, Zoltán Szepes, Gábor Tamás Tóth, Áron Vincze, Renáta Bor, Ágnes Milassin, Anna Fábián, Ferenc Nagy, Martin Kolar, Martin Bortlik, Dana Duricova, Veronika Hruba, Martin Lukas, Katarina Mitrova, Karin Malickova, Milan Lukas, Péter L Lakatos, Tamás Molnár, Klaudia Farkas
Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort. Expert opinion on drug safety 16 (8) (2017)
Klaudia Farkas, Mariann Rutka, Tamás Ferenci, Ferenc Nagy, Anita Bálint, Renáta Bor, Ágnes Csontos, Anna Fábián, Kata Szántó, Zsuzsanna Végh, Zsuzsanna Kürti, Péter L Lakatos, Zoltán Szepes, Tamás Molnár
Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn's disease and ulcerative colitis - experiences from a single center. Expert opinion on biological therapy 17 (11) (2017)
Mariann Rutka, Renáta Bor, Anita Bálint, Anna Fábián, Ágnes Milassin, Ferenc Nagy, Zoltán Szepes, Mónika Szűcs, László Tiszlavicz, Klaudia Farkas, Tamás Molnár
Diagnostic Accuracy of Five Different Fecal Markers for the Detection of Precancerous and Cancerous Lesions of the Colorectum. Mediators of inflammation 2016 (2016)